In fact, KCTD12 interacts with CDK1 and CDC25B, forming a complex that supports CDK1 phosphorylation and cell cycle progression [103], while pharmacological inhibition of KCTD12-CDK1 interaction suppresses growth of colon cancer cells in vitro and in vivo [102]. This evidence concerns the gene CDK1 and colonic neoplasm.